EXTIMA — ROADMAP (Extended Edition)
From Prototype to Full-Scale Neuromorphic Platform
0–3 months (Kickoff Phase)
– Finalize MVP architecture and core component list.
– Prepare early CAD/3D layouts (visual + engineering drafts).
– Assemble first contractor network: design, electronics, materials.
– Set up internal documentation hub (PPA, TM, IP binders, NDA system).
– Deploy investor funnel: One-Pager → Investor Hub → Pitch Deck.
– Prepare ground for multicrowd launch (Kickstarter + Indiegogo).
– Conduct preliminary stress-test planning for biosensing baseline.
Today (Concept Stage)
EXTIMA is defined as a next-generation neuromorphic wearable — combining adaptive biosensing, real-time modeling, and holographic interaction.
The mission is to predict physiological shifts before they escalate and create a new class of human-state protection.
0–6 months (Prototype)
– Build and showcase the first functional prototype (GEN-1).
– Use premium-grade materials (IP68, shock and dust resistance).
– Introduce baseline biosensing: micro-vibrations, HRV, thermal drift, stress markers.
– Integrate simplified holographic interface.
– Share early units with selected partners and backers.
6–18 months (Validation & Expansion)
– Reinforce biosensor arrays with multimodal layers.
– Run early-access testing under NDA.
– Validate durability in operational conditions.
– Begin academic and lab-level collaborations.
– Expand internal datasets for neuromorphic modeling.
18–24 months (Collaborations & Infrastructure)
– Establish strategic alliances with universities and R&D groups.
– Build in-house research capabilities for rapid iteration.
– Enhance AI modeling algorithms for predictive accuracy.
– Integrate continuous biosignal adaptation.
24–36 months (Regulatory Alignment)
– Begin structured documentation: ISO, CE, FCC.
– Prepare early FDA-alignment documentation without blocking traction.
– Finalize compliance structure for international markets.
– Run pre-market risk assessments and simulated failure tests.
36+ months (Future Vision)
– Commercial rollout as the world’s first neuromorphic cognitive platform.
– Launch full-cycle production facility (chip → assembly → packaging).
– Expand to global markets: performance, resilience, emergency readiness.
– Build corporate partner ecosystem and technical alliances.
3–5 Years (Scale & Intelligence)
– Release EXTIMA GEN-2 with enhanced neuromorphic architecture.
– Introduce predictive-behavior loop and personalized baselines.
– Establish international R&D hubs in EU, UAE, Singapore.
– Integrate EXTIMA into emergency response and resilience frameworks.
– Move toward mass-manufacturing cycles with partner factories.
– Deploy enterprise-grade EXTIMA systems for high-risk industries.
Full Vision (Long-Term)
EXTIMA becomes a global human-state protection platform:
– Neuromorphic processing as a global safety standard.
– Integration into civil safety systems (smart cities, emergency networks).
– Deep personalization through long-term biosignal learning.
– Safety-first human performance enhancement (within legal boundaries).
– Zero–intrusion architecture that keeps the user protected at all times.
– Worldwide ecosystem of partners, labs, and manufacturers.